Clinical Trial Update: A Phase Ⅰ/Ⅱa Study of SNUG01 in Adult Subjects With ALS [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2a clinical trial of SNUG01 for amyotrophic lateral sclerosis is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Drugs mentioned

• SNUG01 (SNUG01)

Snippet

Sponsor: SineuGene Therapeutics Co., Ltd. | Conditions: Amyotrophic Lateral Sclerosis (ALS) | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING